Einträge von Choe, Hannah auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 5.
2023
Meyers, Gabrielle
, Hamadani, Mehdi
, Martens, Michael, Ali, Haris, Chevallier, Patrice, Choe, Hannah, Harris, Andrew C.
, Holler, Ernst
, van Hooren, Eric, Klaassen, Willem, Leifer, Eric, van Oosterhout, Ypke, Perez, Lia, Pusic, Iskra, Stelljes, Matthias, van der Velden, Walter, Ammatuna, Emanuele, Beauvais, David, Cornillon, Jérôme, Maziarz, Richard T., Schetelig, Johannes, Romeril, Jennifer, MacMillan, Margaret L.
, Levine, John E. und Socié, Gérard
(2023)
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Bone Marrow Transplantation 58 (12), S. 1416-1418.
Volltext nicht vorhanden.
, Hamadani, Mehdi
, Martens, Michael, Ali, Haris, Chevallier, Patrice, Choe, Hannah, Harris, Andrew C.
, Holler, Ernst
, van Hooren, Eric, Klaassen, Willem, Leifer, Eric, van Oosterhout, Ypke, Perez, Lia, Pusic, Iskra, Stelljes, Matthias, van der Velden, Walter, Ammatuna, Emanuele, Beauvais, David, Cornillon, Jérôme, Maziarz, Richard T., Schetelig, Johannes, Romeril, Jennifer, MacMillan, Margaret L.
, Levine, John E. und Socié, Gérard
(2023)
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Bone Marrow Transplantation 58 (12), S. 1416-1418.
Volltext nicht vorhanden.
Etra, Aaron, Capellini, Alexandra, Alousi, Amin, Al Malki, Monzr M., Choe, Hannah, DeFilipp, Zachariah, Hogan, William J., Kitko, Carrie L., Ayuk, Francis, Baez, Janna, Gandhi, Isha, Kasikis, Stelios, Gleich, Sigrun, Hexner, Elizabeth, Hoepting, Matthias, Kapoor, Urvi, Kowalyk, Steven, Kwon, Deukwoo, Langston, Amelia, Mielcarek, Marco, Morales, George, Özbek, Umut, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Spyrou, Nikolaos, Young, Rachel, Chen, Yi-Bin, Ferrara, James L. M. und Levine, John E.
(2023)
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
Blood 141 (5), S. 481-489.
Volltext nicht vorhanden.
Al Malki, Monzr M., London, Kaitlyn, Baez, Janna, Akahoshi, Yu
, Hogan, William J.
, Etra, Aaron, Choe, Hannah, Hexner, Elizabeth
, Langston, Amelia
, Abhyankar, Sunil, Ponce, Doris M., DeFilipp, Zachariah, Kitko, Carrie L., Adekola, Kehinde, Reshef, Ran, Ayuk, Francis, Capellini, Alexandra, Chanswangphuwana, Chantiya, Eder, Matthias, Eng, Gilbert, Gandhi, Isha, Grupp, Stephan, Gleich, Sigrun, Holler, Ernst, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kowalyk, Steven, Morales, George, Özbek, Umut, Rösler, Wolf, Spyrou, Nikolaos, Yanik, Gregory, Young, Rachel, Chen, Yi-Bin, Nakamura, Ryotaro, Ferrara, James L. M. und Levine, John E.
(2023)
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.
Blood Advances 7 (17), S. 5189-5198.
Volltext nicht vorhanden.
, Hogan, William J.
, Etra, Aaron, Choe, Hannah, Hexner, Elizabeth
, Langston, Amelia
, Abhyankar, Sunil, Ponce, Doris M., DeFilipp, Zachariah, Kitko, Carrie L., Adekola, Kehinde, Reshef, Ran, Ayuk, Francis, Capellini, Alexandra, Chanswangphuwana, Chantiya, Eder, Matthias, Eng, Gilbert, Gandhi, Isha, Grupp, Stephan, Gleich, Sigrun, Holler, Ernst, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kowalyk, Steven, Morales, George, Özbek, Umut, Rösler, Wolf, Spyrou, Nikolaos, Yanik, Gregory, Young, Rachel, Chen, Yi-Bin, Nakamura, Ryotaro, Ferrara, James L. M. und Levine, John E.
(2023)
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease.
Blood Advances 7 (17), S. 5189-5198.
Volltext nicht vorhanden.
2022
Etra, Aaron, Gergoudis, Stephanie, Morales, George, Spyrou, Nikolaos, Shah, Jay
, Kowalyk, Steven, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Chen, Yi-Bin, Choe, Hannah, DeFilipp, Zachariah, Gandhi, Isha, Hexner, Elizabeth, Hogan, William J., Holler, Ernst, Kapoor, Urvi, Kitko, Carrie L., Kraus, Sabrina, Lin, Jung-Yi, Al Malki, Monzr, Merli, Pietro
, Pawarode, Attaphol, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Van Hyfte, Grace, Weber, Daniela, Wölfl, Matthias, Young, Rachel, Özbek, Umut, Ferrara, James L. M. und Levine, John E.
(2022)
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Blood Advances 6 (12), S. 3707-3715.
Volltext nicht vorhanden.
, Kowalyk, Steven, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Chen, Yi-Bin, Choe, Hannah, DeFilipp, Zachariah, Gandhi, Isha, Hexner, Elizabeth, Hogan, William J., Holler, Ernst, Kapoor, Urvi, Kitko, Carrie L., Kraus, Sabrina, Lin, Jung-Yi, Al Malki, Monzr, Merli, Pietro
, Pawarode, Attaphol, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Van Hyfte, Grace, Weber, Daniela, Wölfl, Matthias, Young, Rachel, Özbek, Umut, Ferrara, James L. M. und Levine, John E.
(2022)
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
Blood Advances 6 (12), S. 3707-3715.
Volltext nicht vorhanden.
2021
Zewde, Makda Getachew, Morales, George, Gandhi, Isha, Özbek, Umut, Aguayo-Hiraldo, Paibel, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Choe, Hannah, DeFilipp, Zachariah, Etra, Aaron, Grupp, Stephan, Hexner, Elizabeth O., Hogan, William, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kitko, Carrie L., Kowalyk, Steven, Meedt, Elisabeth, Merli, Pietro, Nakamura, Ryotaro, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Weber, Daniela, Wölfl, Matthias, Yanik, Gregory, Young, Rachel, Levine, John E., Ferrara, James L. M. und Chen, Yi-Bin
(2021)
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Transplantation and Cellular Therapy 27 (12), 988.e1-988.e7.
Volltext nicht vorhanden.
